Literature DB >> 26400478

[Fertility preservation in breast cancer patients by embryo cryopreservation after ovarian stimulation with letrozole and FSH].

Matthias W Beckmann1, Sebastian Findeklee2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26400478     DOI： 10.1007/s00066-015-0896-1

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  4 in total

1.  Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy.

Authors:  Kutluk Oktay; Ariel Hourvitz; Gulnaz Sahin; Ozgur Oktem; Bradley Safro; Aylin Cil; Heejung Bang
Journal:  J Clin Endocrinol Metab       Date:  2006-08-01       Impact factor: 5.958

Review 2.  IVF for fertility preservation in breast cancer patients--efficacy and safety issues.

Authors:  M Shapira; H Raanani; D Meirow
Journal:  J Assist Reprod Genet       Date:  2015-07-01       Impact factor: 3.412

3.  Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study.

Authors:  Amr A Azim; Maria Costantini-Ferrando; Kutluk Oktay
Journal:  J Clin Oncol       Date:  2008-06-01       Impact factor: 44.544

Review 4.  Review. Fertility preservation for young female cancer patients.

Authors:  Theodoros Maltaris; Matthias W Beckmann; Ralf Dittrich
Journal:  In Vivo       Date:  2009 Jan-Feb       Impact factor: 2.155
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.